亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

供應(yīng)大黃酸廠家CAS 登錄號(hào):478-43-3

 
 
單價(jià) 面議對(duì)比
詢價(jià) 暫無
發(fā)貨 湖北武漢市預(yù)售,付款后7天內(nèi)
型號(hào) 478-43-3
過期 長(zhǎng)期有效
更新 2011-01-30 16:15
 

湖北康寶泰精細(xì)化工有限公司(銷售部)

企業(yè)會(huì)員第15年
資料未認(rèn)證
保證金未繳納
詳細(xì)說明

大黃酸
英文名:Rhein
植物來源:掌葉大黃Rheum palmatum L的根莖。
化學(xué)名:1.8-二羥基-3-羧基蒽醌
CAS 登錄號(hào):478-43-3
分子式:C15H8O6
分子量:284.21
外觀:為咖啡色針晶,升華后為黃色針晶。
功能:(一)抗腫瘤活性,抗菌,抗炎,大黃酸能抑制生物體抗體產(chǎn)生,抑制碳粒廓清能力,減輕免疫器官的重量,降低白細(xì)胞數(shù)。能使尿中鈉、鉀離子濃度升高,促進(jìn)輸尿管蠕動(dòng),增加尿量。
舉報(bào)收藏 0評(píng)論 0
更多>本企業(yè)其它產(chǎn)品
供應(yīng)西洛他唑廠家CAS號(hào): 73963-72-1 供應(yīng)托拉塞米廠家CAS號(hào):56211-40-6 供應(yīng)鹽酸奧昔布寧廠家CAS號(hào):1508-65-2 供應(yīng)呋塞米廠家CAS號(hào):54-31-9 供應(yīng)依他尼酸廠家CAS號(hào):58-54-8 供應(yīng)三氯噻嗪廠家CAS號(hào):133-67-5 供應(yīng)鹽酸可樂定廠家CAS編號(hào): 4205-91-8 供應(yīng)尼群地平廠家CASNO :39562-70-4
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |